Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03648814
NA

Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

Sponsor: Prince of Songkla University

View on ClinicalTrials.gov

Summary

To prospect studying the efficacy and safety of treating NVG with the intracameral versus the intravitreal injection of Bevacizumab.

Official title: Efficacy and Safety of Intracameral Versus Intravitreal Bevacizumab Injection as an Adjunctive Therapy Before Trabeculectomy With Mitomycin-C in Neovascular Glaucoma: A Prospective Randomized Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2018-08-01

Completion Date

2026-07-01

Last Updated

2025-08-21

Healthy Volunteers

No

Interventions

PROCEDURE

Intracameral injection

A/C injection of 1.25 mg/0.05 mL bevacizumab

PROCEDURE

Intravitreal injection

Vitreous injection of 1.25 mg/0.05 mL bevacizumab

Locations (1)

Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University

Hat Yai, Changwat Songkhla, Thailand